Ali Moresco
Founder, Advocate + Speaker
A global leader in chronic disease, lyme disease, resilience and modern healthcare public relations.
"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru.”
Keep Up with Ali
About Ali Moresco
Ali Moresco is a healthcare communications strategist, patient advocate, and philanthropist whose work sits at the intersection of media, medicine, and community impact. She is the founder and CEO of Moresco Public Relations + Communications (AMPR), a modern communications firm specializing in healthcare PR, podcast strategy, and digital storytelling.
As both a strategist and a “professional patient,” Ali has translated her lived experience into communications campaigns that bridge the gap between researchers, physicians, healthcare brands, and patient communities. She has guided her clients to coverage in some of the world’s most respected outlets, including The New York Times, The Wall Street Journal, Forbes, USA Today, and more. Through AMPR, she has positioned physicians, researchers, and mission-driven companies as thought leaders while amplifying patient voices in the national conversation.
Ali has become widely recognized for building healthcare thought leaders, giving them a voice in the global healthcare conversation and ensuring their expertise reaches the patients and communities who need it most, often times through podcast strategies that secure clients coverage on leading shows like the Dr. Josh Axe Show, Culture Apothecary and The Art of Being Well with Dr. Will Cole.
Ali’s advocacy extends far beyond her professional practice. She has raised millions of dollars for tick-borne illness research, actively lobbied in Washington, D.C., and played a role in advancing federal legislation, including the Kay Hagan Tick Act, which secured millions in federal funding for tick-borne disease prevention and research. Ali has stood besides politicians like Senator Kirsten Gillibrand and Senator Richard Blumenthal at press conferences announcing their legislative plans and called for reform.
In 2025, Ali served on a small strategic committee that partnered with New York Fashion Week to bring Lyme disease awareness to a global stage through the Project Lab Coat fashion show in partnership with Runway7. This groundbreaking initiative marked a historic collaboration between three of the nation’s leading 501(c)(3) nonprofits in the tick-borne disease space, uniting the community in an unprecedented way and amplifying the patient voice on one of the world’s most visible platforms.
Ali has become a sought-after speaker and thought leader, delivering talks and workshops on podcast PR, healthcare storytelling, advocacy, and resilience. Drawing from her journey with chronic illness, Ali shares the mindset shifts and strategies high achievers can use to thrive—in life and in business. Her insights have been shared across conferences, congressional events, nonprofit summits, and media training sessions for physicians, CEOs, founders and patient leaders alike. She is also co-host of two podcasts—Slightly Spiritual and The Feel Better Podcast—which spotlight conversations on wellness, resilience, and chronic illness.
Ali was recently named host and producer of Pathobiome Perspectives, a new series created in collaboration with the Pathobiome Research Center at PCOM that explores the evolving science connecting infection and chronic disease.
Ali currently serves as Executive Board Chair of Project Lyme, one of the nation’s leading Lyme nonprofits, where she helps shape grantmaking, awareness campaigns, and research priorities. She also lends her expertise to broader philanthropic causes as an Executive Board member of the Alpha-Gal Foundation, supporting AGS research through community-driven fundraising.
Her leadership and impact have earned national recognition. In 2025, Ali was named to the Nashville Business Journal’s “40 Under 40” list, honoring her as one of the city’s most influential young leaders.